Pricing Log in Create free account

Anebulo Pharmaceuticals, Inc. (ANEB) vs Dyadic International Inc. (DYAI)

Anebulo Pharmaceuticals, Inc. and Dyadic International Inc. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and Dyadic International Inc. are of similar size ($17.6M and $16.8M). Anebulo Pharmaceuticals, Inc. has the higher net margin (0.00% vs −200.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Anebulo Pharmaceuticals, Inc. leads on 8 and Dyadic International Inc. on 3.

Valuation

Metric ANEB DYAI Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.93 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.03 n/m 0.64
EV/Sales n/m 4.03 9.21
Earnings yield 0.00% (56.10%) (33.15%)
Free cash flow yield 0.00% (50.30%) (25.50%)

Profitability

Metric ANEB DYAI Biotechnology median
Gross margin — 16.24% 65.16%
Operating margin 0.00% (195.47%) 0.00%
Net margin 0.00% (200.46%) 0.00%
Free cash flow margin 0.00% (194.73%) 0.00%
Return on equity (69.69%) 522.58% (56.36%)
Return on assets (63.17%) (103.88%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANEB DYAI Biotechnology median
Revenue growth (TTM) — (8.05%) 6.02%
EPS growth (last fiscal year) 21.88% (15.00%) 30.26%
Revenue growth, 5-year CAGR — 14.04% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANEB DYAI Biotechnology median
Debt to equity 0.00 (2.11) 0.00
Current ratio 6.24 1.65 4.72
Net debt to EBITDA 1.32 0.49 0.96

Dividend

Metric ANEB DYAI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANEB DYAI Biotechnology median
Market cap 17.60m 16.80m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack